In a regulatory filing, Bank OZK notes that on May 29, the company’s management received inquiries regarding a recently published analyst research report, and in conversations with investors management provided information on two loans, the “San Diego Life Science Project” loan and the “Atlanta Mixed Use Project” loan. In both cases, management stated that it “is confident in the project.” During the conversations with investors, management referred to its April 17 “Management Comments” document and reiterated the guidance contained therein, the filing noted.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OZK:
- American downgraded, United upgraded: Wall Street’s top analyst calls
- Bank OZK downgraded to Sell from Buy at Citi
- Bank OZK price target lowered to $47 from $48 at Truist
- Bank OZK price target raised to $47 from $45 at Keefe Bruyette
- Bank OZK jumps over 3% after reporting Q1 profit ahead of estimates